stay updated with our newsletter

Close this search box.

Caprylic Acid Shows Greater Plasma Ketone Response in Humans Consuming Different Medium-Chain Triglycerides

caprylic acid

Which medium chain fatty acids–caproic acid, caprylic acid, capric acid or lauric acid–has more ketogenic properties? Medium chain triglycerides (MCT) are ketogenic but the relationship between the change in plasma ketones and changes in plasma medium chain fatty acids (MCFA) is not well-known.

As researchers learn more about fasting and dietary carbohydrate restriction, there is greatercaprylic acid interest in ketones, β-hydroxybutyrate (β-HB) and acetoacetate (AcAc), which are produced by the liver in restricted eating conditions. In this study, published by Frontiers in Nutrition, researchers assessed the relationship between the change in plasma ketones, and octanoate, decanoate and dodecanoate in plasma total lipids during an 8 hour metabolic study day.

The following are the primary medium-chain fatty acids:

  • C6: Caproic acid or hexanoic acid.
  • C8: Caprylic acid or octanoic acid.
  • C10: Capric acid or decanoic acid.
  • C12: Lauric acid or dodecanoic acid.

Previous studies using ketogenic therapies or diet, supplements or IV infusion, have shown beneficial effects on cognitive outcomes. A better understanding of the plasma medium-chain fatty acids (MCFA) and ketone response to various medium-chain triglycerides (MCT) could potentially help improve the formulation of ketogenic MCT supplements and might also provide a way of evaluating the compliance of patients and participants taking such supplements in clinical trials, especially in an older population experiencing cognitive decline.

Ketones provide up to 80% of the brain’s energy requirements during long-term fasting. Aside from energy or carbohydrate restriction, a common way to increase plasma ketones is by the ingestion of MCT, which provides MCFA, i.e., saturated fatty acids of 6–12 carbons in chain length. Mammalian milk, coconut oil and palm oil contain various types of MCFA. MCFA are considered ketogenic because they are more rapidly metabolized than long-chain fatty acids.

Unlike long-chain fatty acids (≥14 carbons), which are absorbed via the lymphatic system and incorporated into circulating chylomicrons before reaching the liver, 8 and 10 carbon MCFA reach the liver directly via the portal vein. Eight-carbon MCFA are also more rapidly oxidized compared to long-chain fatty acids, because they cross the mitochondrial inner membrane without carnitine-dependent transport.

Methods/ For clarity, in this study, the abbreviations—C8, C10, and C12—are used when referring to the dietary supplement provided, whereas the full names—octanoate, decanoate, and dodecanoate—are used when referring to the plasma levels of these MCFA. In this study, subjects consumed the first 20 ml dose of the homogenized test oil is taken with breakfast and a second 20 ml dose is taken 4 h later without an accompanying meal. A total of n = 9 people (n = 7 men and n = 2 women) completed all the tests except for C10 (n = 8).

On each metabolic study day, participants arrived at 7:30 a.m. after a 12 h overnight fast and a minimum of 24 h without alcohol intake. A forearm venous catheter was inserted and a fasting baseline blood sample was withdrawn (Time 0). At about 8 a.m., participants received the standard breakfast during which they also consumed the test or CTL drink. The breakfast consisted of two pieces of toast with raspberry jam, a piece of cheese, and two scrambled eggs (total of 470 calories, 19.5 g of fat, 24.2 g of protein and 55 g of carbohydrate). Four hours later (at about noon), a second dose of the test drink was given but with no other food. Water was available ad libitum throughout the study day.

Venous forearm blood samples were taken in EDTA tubes as baseline (pre-dose) and every 30 min during the 8 h study period, with the first post-dose sample taken 30 min after the test drink was consumed. Blood samples were centrifuged at 2846 G for 10 min at 4°C and plasma stored at −80°C until analyzed.

The objectives of the present study were to assess:

  1. Changes in MCFA (octanoate, decanoate and dodecanoate) in plasma total lipids after various MCT treatments during a metabolic study day;
  2. How changes in octanoate, decanoate, and dodecanoate in plasma total lipids were related to changes in plasma ketones and the plasma ratio of BHB/AcAc during the metabolic study day, and;
  3. The ketogenic effect of trilaurin (C12 triglyceride).

Results / This study demonstrates that there is a significantly greater ketogenic effect in humans of an oral dose of C8 compared to C10 or C12. This is due to a difference in their effect on ketogenesis, and not to substantially different increases in the levels of octanoate, decanoate or dodecanoate in plasma total lipids after an oral dose of these MCT.

Also shown here is that in relation to changes in plasma MCFA, C8 has a significantly stronger dose response effect on plasma ketones than C10 or C12.

  • For example, at 400 μM of each MCFA in plasma total lipids, plasma ketones were about three times higher after C8 than after C10 and two times higher after C10 than C12.
  • The C10 and C12 were not statistically significantly more ketogenic than the CTL condition. Plasma octanoate and decanoate were almost undetectable in all our baseline or CTL test samples so the presence of these two MCFA in plasma total lipids appears to depend on them being consumed quite recently.

How Does Eating a Meal Affect Ketogenesis?

The design this metabolic study allowed for the researchers to evaluate the effect of consuming a meal on the plasma ketone and MCFA responses to the test substances. Here is what they found:

  1. Compared to not consuming a meal at midday, consuming a breakfast containing 470 kilocalories with the 20 ml dose of C8, C10, or C12 did not significantly affect the area under the curve (AUC) of plasma octanoate, decanoate or dodecanoate.
  2. It did significantly reduce the AcAc and β-HB AUCs by ≥50% for the tests with C8C10, C8, C10, or C12 compared to CTL.
  3. Hence, a carbohydrate-rich test breakfast does not appear to affect absorption of octanoate, decanoate, or dodecanoate or their level in plasma total lipids.
  4. However, the breakfast did reduce the conversion of these MCFA to ketones during the following 3–4 h, possibly due to post-prandial insulin secretion. This may have implications for planning long-term ketogenic interventions based on MCT because, in order to maximize the resulting ketosis, it may be advantageous to give such interventions without a meal, i.e., as a stand-alone evening snack or as a replacement for breakfast.
  5. On the other hand, the meal may be beneficial because it tends to dampen the transitory gastrointestinal discomfort commonly seen with MCT, an effect that was not formally evaluated in this study.
  6. Plasma ketones returned toward baseline relatively quickly after C8 or C8C10 but plasma octanoate, decanoate and dodecanoate remained elevated for at least 8 h, suggesting that the spot checks of plasma MCFA could have some utility for monitoring compliance when one or other of these fatty acids is consumed in a longer term study.

Conclusion/ The C8 was the most ketogenic supplement evaluated in these one-day metabolic tests. The C10 was poorly ketogenic but may promote glycolysis and lactate release in astrocytes, which could improve mitochondrial function and contribute to an anti-epileptic effect by inhibiting the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. Further research is needed to determine whether there are biological effects of C8, C10, or C12 in humans independent of their effects on ketogenesis.

Click Here for Full Text Study

Source: St-Pierre V, Vandenberghe C, Lowry CM, et al. Plasma Ketone and Medium Chain Fatty Acid Response in Humans Consuming Different Medium Chain Triglycerides During a Metabolic Study Day. Front Nutr. 2019;6:46. Published 2019 Apr 16. doi:10.3389/fnut.2019.00046




Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.